Genzyme Finally Agrees to US$20.1 B Plus CVR Takeover by Sanofi-aventis
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 3 (Table of Contents)
Published: 2 Mar-2011
DOI: 10.3833/pdr.v2011.i3.1440 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
After a protracted period of at times hostile negotiations, Genzyme has finally agreed to accept an improved takeover bid of US$74 per share in cash, or approximately US$20...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS